| VERTEX PHARMACEUTICALS INC | 186.38 / +0.14% |
| Date/Time | 01/15 / 17:32 |
| Chg. / Chg.(%) | 0.26 / +0.14% |
| Bid | - |
| Ask | - |
| Open | 186.02 |
| Previous Close | 186.12 |
| High | 187.82 |
| Low | 186.02 |
| Volume [EUR] | 19,828.30 |
| Volume [Units] | 106 |
| Price fixings | 5 |
| ISIN | US92532F1003 |
| Security | VRTX |
| Exchange | Vienna Global Market |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 185.760 |  |
|
| NASDAQ | 225.5500 | |
2,242,187 |
| IEX | 225.55 | |
200,041 |
| Cboe US | 225.54 | |
68,436 |
| TradeGate | 186.660 | |
898 |
| London Inter.. | 225.26 | |
356 |
| Frankfurt | 187.1800 | |
150 |
| gettex | 188.100 |  |
116 |
| Vienna Globa.. | 186.38 | |
106 |
| Xetra | 186.64 | |
90 |
| Stuttgart | 187.160 | |
52 |
| Berlin | 187.22 | |
16 |
| Mexico | 4,500.00 | |
7 |
| München | 185.02 | |
0 |
| Düsseldorf | 187.56 | |
0 |
| Hannover | 185.02 |  |
0 |
| Hamburg | 185.02 | |
0 |
News
- Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company
01/12/2021 / 13:00 - GlobeNewswire - Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
12/17/2020 / 14:00 - GlobeNewswire - Sarepta Therapeutics Announces Executive Management Changes
12/14/2020 / 14:30 - GlobeNewswire - CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
12/14/2020 / 14:00 - GlobeNewswire - Spero Therapeutics Announces First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease
12/10/2020 / 14:00 - GlobeNewswire
Real-time